Cargando…

Population-level estimates of hepatitis C reinfection post scale-up of direct-acting antivirals among people who inject drugs

BACKGROUND & AIMS: Scale-up of highly effective direct-acting antivirals (DAAs) for HCV among people who inject drugs (PWID) in Scotland has led to a reduction in the prevalence of viraemia in this population. However, the extent of reinfection among those treated with DAAs remains uncertain. We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yeung, Alan, Palmateer, Norah E., Dillon, John F., McDonald, Scott A., Smith, Shanley, Barclay, Stephen, Hayes, Peter C., Gunson, Rory N., Templeton, Kate, Goldberg, David J., Hickman, Matthew, Hutchinson, Sharon J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852744/ https://www.ncbi.nlm.nih.gov/pubmed/34634387 http://dx.doi.org/10.1016/j.jhep.2021.09.038

Ejemplares similares

Rapid Decline in HCV Incidence among People Who Inject Drugs Associated with National Scale-Up in Coverage of a Combination of Harm Reduction Interventions
por: Palmateer, Norah E., et al.
Publicado: (2014)

Increased risk of HIV and other drug-related harms associated with injecting in public places: national bio-behavioural survey of people who inject drugs
por: Trayner, Kirsten M.A., et al.
Publicado: (2020)

High willingness to use drug consumption rooms among people who inject drugs in Scotland: findings from a national bio-behavioural survey among people who inject drugs
por: Trayner, Kirsten M.A., et al.
Publicado: (2021)

Examining the impact of the first wave of COVID-19 and associated control measures on interventions to prevent blood-borne viruses among people who inject drugs in Scotland: an interrupted time series study
por: Trayner, Kirsten M.A., et al.
Publicado: (2022)

Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) – a natural experiment (protocol)
por: Hickman, Matthew, et al.
Publicado: (2019)

The provision of non-needle/syringe drug injecting paraphernalia in the primary prevention of HCV among IDU: a systematic review
por: Gillies, Michelle, et al.
Publicado: (2010)

Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals
por: Martin, Natasha K, et al.
Publicado: (2013)

Impact of current and scaled‐up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings—what is required to achieve the WHO's HCV elimination targets?
por: Ward, Zoe, et al.
Publicado: (2018)

Cost-effectiveness and budgetary impact of HCV treatment with direct-acting antivirals in India including the risk of reinfection
por: Chaillon, Antoine, et al.
Publicado: (2019)

Combination Interventions to Prevent HCV Transmission Among People Who Inject Drugs: Modeling the Impact of Antiviral Treatment, Needle and Syringe Programs, and Opiate Substitution Therapy
por: Martin, Natasha K., et al.
Publicado: (2013)

Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs
por: Platt, Lucy, et al.
Publicado: (2017)

Knowledge of hepatitis C and awareness of reinfection risk among people who successfully completed direct acting antiviral therapy
por: Yazdani, Kiana, et al.
Publicado: (2022)

The impact of direct‐acting antivirals on hepatitis C viraemia among people who inject drugs in England; real‐world data 2011–2018
por: Bardsley, Megan, et al.
Publicado: (2021)

Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta‐analysis
por: Platt, Lucy, et al.
Publicado: (2017)

Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation
por: Martin, Natasha K., et al.
Publicado: (2016)

Late Relapse and Reinfection in HCV Patients Treated with Direct-Acting Antiviral (DAA) Drugs
por: Minosse, Claudia, et al.
Publicado: (2021)

Real‐world outcomes of rapid regional hepatitis C virus treatment scale‐up among people who inject drugs in Tayside, Scotland
por: Byrne, Christopher J., et al.
Publicado: (2021)

Infections with Spore-forming Bacteria in Persons Who Inject Drugs, 2000–2009
por: Palmateer, Norah E., et al.
Publicado: (2013)

Relapse or reinfection after failing hepatitis C direct acting antiviral treatment: Unravelled by phylogenetic analysis
por: Cuypers, Lize, et al.
Publicado: (2018)

The Potential Impact of a Hepatitis C Vaccine for People Who Inject Drugs: Is a Vaccine Needed in the Age of Direct-Acting Antivirals?
por: Stone, Jack, et al.
Publicado: (2016)

High Rates of Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection in People Who Inject Drugs: A Prospective Cohort Study
por: Sacks-Davis, Rachel, et al.
Publicado: (2013)

Modelling the impact of incarceration and prison‐based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland
por: Stone, Jack, et al.
Publicado: (2017)

Mixed Genotype Hepatitis C Infections and Implications for Treatment
por: McNaughton, Anna L, et al.
Publicado: (2014)

Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisons
por: Martin, Natasha K, et al.
Publicado: (2013)

Hepatitis C reinfection in former and active injecting drug users in Belgium
por: Busschots, Dana, et al.
Publicado: (2021)

The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection
por: Kellam, Paul, et al.
Publicado: (2020)

COVID-19 reinfection: prolonged shedding or true reinfection?
por: Falahi, S., et al.
Publicado: (2020)

Are Interferon-Free Direct-Acting Antivirals for the Treatment of HCV Enough to Control the Epidemic among People Who Inject Drugs?
por: Lima, Viviane D., et al.
Publicado: (2015)

Comparison of the Efficacies of Direct-Acting Antiviral Treatment for HCV Infection in People Who Inject Drugs and Non-Drug Users
por: Hsu, Jui-Ting, et al.
Publicado: (2022)

Modeling hepatitis C micro-elimination among people who inject drugs with direct-acting antivirals in metropolitan Chicago
por: Tatara, Eric, et al.
Publicado: (2022)

In a Real-Life Setting, Direct-Acting Antivirals to People Who Inject Drugs with Chronic Hepatitis C in Turkey
por: Sarıgül Yıldırım, Figen, et al.
Publicado: (2022)

Hepatitis C Reinfection in People Who Inject Drugs in Resource-Limited Countries: A Systematic Review and Analysis
por: Muller, Abbe, et al.
Publicado: (2020)

Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infection
por: Innes, Hamish, et al.
Publicado: (2021)

Randomized clinical trial: Direct‐acting antivirals as treatment for hepatitis C in people who inject drugs: Delivered in needle and syringe programs via directly observed therapy versus fortnightly collection
por: Beer, Lewis, et al.
Publicado: (2022)

Directly Acting Antiviral-Based Treatment for HCV-Infected Persons Who Inject Drugs: A Multicenter Real-Life Study
por: Messina, Vincenzo, et al.
Publicado: (2020)

Declines in Depressive Symptoms Among People who Inject Drugs Treated With Direct-Acting Antivirals While on Opioid Agonist Therapy
por: Pericot-Valverde, Irene, et al.
Publicado: (2020)

Hepatitis C Resistance-Associated Substitutions Among People Who Inject Drugs Treated With Direct-Acting Antiviral-Containing Regimens
por: Akiyama, Matthew J, et al.
Publicado: (2021)

Patient Centeredness in Hepatitis C Direct-Acting Antiviral Treatment Delivery to People Who Inject Drugs: A Scoping Review
por: Abdelwadoud, Moaz, et al.
Publicado: (2020)

Machine learning models to accelerate the design of polymeric long-acting injectables
por: Bannigan, Pauric, et al.
Publicado: (2023)

Low Adherence Achieves High HCV Cure Rates Among People Who Inject Drugs Treated With Direct-Acting Antiviral Agents
por: Norton, Brianna L, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qa8o21f0ejqmt7mbhbh9qlut74